Royalty Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 29, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	14,989	10,948	11,306	16,312	15,050	15,881
Market Cap Growth	12.92%	-3.17%	-30.69%	8.38%	-5.23%	-
Enterprise Value	24,430	20,604	19,119	25,576	23,466	23,224
Last Close Price	33.55	23.77	23.66	33.29	32.56	-
PE Ratio	22.99	13.20	11.01	407.00	27.62	39.23
PS Ratio	7.48	5.01	5.31	7.79	7.48	9.15
PB Ratio	1.83	1.10	1.24	1.83	1.67	1.96
P/TBV Ratio	3.21	1.63	1.92	3.11	2.97	4.06
P/OCF Ratio	7.31	4.09	4.18	8.13	8.48	9.55
EV/Sales Ratio	12.35	9.42	8.98	12.22	11.66	13.39
EV/EBITDA Ratio	-	-	14.11	29.44	18.36	16.88
EV/EBIT Ratio	17.93	16.51	14.16	29.62	18.65	17.11
Debt / Equity Ratio	0.93	0.74	0.61	0.75	0.69	0.59
Debt / EBITDA Ratio	-	-	4.10	7.66	4.88	3.46
Asset Turnover	0.13	0.13	0.14	0.13	0.14	0.15
Quick Ratio	3.47	1.43	7.78	2.11	16.77	8.73
Current Ratio	3.48	1.44	7.90	2.19	16.81	8.76
Return on Equity (ROE)	13.11%	13.03%	17.34%	2.33%	12.32%	21.22%
Return on Assets (ROA)	5.22%	4.67%	5.62%	3.36%	5.33%	7.29%
Return on Capital Employed (ROCE)	8.30%	7.60%	9.20%	5.90%	8.20%	10.60%
Earnings Yield	4.35%	7.58%	9.08%	0.25%	3.62%	5.02%
Dividend Yield	2.34%	3.41%	3.06%	2.14%	1.84%	-
Payout Ratio	52.56%	43.83%	31.57%	778.21%	46.02%	40.80%
Buyback Yield / Dilution	3.98%	1.46%	-37.66%	-5.59%	-10.48%	-
Total Shareholder Return	6.32%	4.87%	-34.60%	-3.45%	-8.64%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.